Mucosal administration of anti-bacterial antibody provides long-term cross-protection against Pseudomonas aeruginosa respiratory infection
A. Pitiot, M. Ferreira, C. Parent, C. Boisseau, M. Cortes, L. Bouvart, C. Paget, N. Heuze-Vourc'h, T. Secher
This study shows that mucosal delivery of anti-bacterial antibodies provides rapid pathogen neutralization and long-term cross-protection against secondary Pseudomonas aeruginosa infections.
bioRxiv · Jul 4, 2022Immunology